Literature DB >> 31951022

Identification of potential miRNA biomarkers for traumatic osteonecrosis of femoral head.

Guan-Zhi Liu1, Chen Chen2, Ning Kong1, Run Tian1, Yi-Yang Li1, Zhe Li1, Kun-Zheng Wang1, Pei Yang1.   

Abstract

Traumatic osteonecrosis of femoral head (TONFH) is a common orthopedic disease caused by physical injury in hip. However, the unclear pathogenesis mechanism of TONFH and lacking of simple noninvasive early diagnosis method cause the necessity of hip replacement for most patients with TONFH. In this study, we aimed to identify circulating microRNAs (miRNAs) by integrated bioinformatics analyses as potential biomarker of TONFH. mRNA expression profiles were downloaded from the Gene Expression Omnibus database. Then we combined two miRNA screen methods: Weighted gene co-expression network analysis and fold change based differentially expressed miRNAs analysis. As a result, we identified 14 key miRNAs as potential biomarkers for TONFH. Besides, 302 target genes of these miRNAs were obtained and the miRNA-mRNA interaction network was constructed. Furthermore, the results of Kyoto Encyclopedia of Gene and Genome pathway analysis, Gene Ontology function analysis, protein-protein interaction (PPI) network analysis and PPI network module analysis showed close correlation between these 14 key miRNAs and TONFH. Then we established receiver operating characteristic curves and identified 6-miRNA signature with highly diagnosis value including miR-93-5p (area under the curve [AUC] = 0.93), miR-1324 (AUC = 0.92), miR-4666a-3p (AUC = 0.92), miR-5011-3p (AUC = 0.92), and miR-320a (AUC = 0.89), miR-185-5p (AUC = 0.89). Finally, the results of quantitative real-time polymerase chain reaction confirmed the significantly higher expression of miR-93-5p and miR-320a in the serum of patients with ONFH. These circulating miRNAs could serve as candidate early diagnosis markers and potential treatment targets of TONFH.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  biomarkers; microRNA expression; traumatic osteonecrosis of the femoral head; weighted gene co-expression network analysis

Year:  2020        PMID: 31951022     DOI: 10.1002/jcp.29467

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

Review 1.  The Emerging Role of MicroRNAs in Bone Diseases and Their Therapeutic Potential.

Authors:  Luis Alberto Bravo Vázquez; Mariana Yunuen Moreno Becerril; Erick Octavio Mora Hernández; Gabriela García de León Carmona; María Emilia Aguirre Padilla; Samik Chakraborty; Anindya Bandyopadhyay; Sujay Paul
Journal:  Molecules       Date:  2021-12-30       Impact factor: 4.411

2.  A nine-hub-gene signature of metabolic syndrome identified using machine learning algorithms and integrated bioinformatics.

Authors:  Guanzhi Liu; Sen Luo; Yutian Lei; Jianhua Wu; Zhuo Huang; Kunzheng Wang; Pei Yang; Xin Huang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

3.  Exosomal microRNA⁃93⁃3p secreted by bone marrow mesenchymal stem cells downregulates apoptotic peptidase activating factor 1 to promote wound healing.

Authors:  Caiqi Shen; Changbo Tao; Aijun Zhang; Xueyang Li; Yanping Guo; Hanxiao Wei; Qichuan Yin; Qiang Li; Peisheng Jin
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

4.  Osteogenesis-Related Long Noncoding RNA GAS5 as a Novel Biomarker for Osteonecrosis of Femoral Head.

Authors:  Guanzhi Liu; Sen Luo; Yutian Lei; Ming Jiao; Ruomu Cao; Huanshuai Guan; Run Tian; Kunzheng Wang; Pei Yang
Journal:  Front Cell Dev Biol       Date:  2022-03-22

5.  Differentially expressed serum proteins in children with or without asthma as determined using isobaric tags for relative and absolute quantitation proteomics.

Authors:  Ming Li; Mingzhu Wu; Ying Qin; Huaqing Liu; Chengcheng Tu; Bing Shen; Xiaohong Xu; Hongbo Chen
Journal:  PeerJ       Date:  2020-11-03       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.